Drug intelligence / Profile preview

111In-TJD-31

Development stage
Phase 1
Lead developer
Yong He
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Gamma Emitters → Radiopharmaceuticals
Administration
Intravenous
01

Overview

111In-TJD-31 is an investigational single-photon emission computed tomography (SPECT) imaging tracer designed for the detection and characterization of solid tumors. It consists of a targeting moiety (TJD-31) labeled with the radioactive isotope Indium-111 (111In) that specifically targets placental alkaline phosphatase (ALPP), a cell-surface protein highly expressed in various malignant solid tumors but rarely found in healthy adult tissues. Developed by Yonghe Medical in collaboration with Tuo Jiding (Jiaxing) Pharmaceutical Technology, 111In-TJD-31 is being evaluated in exploratory clinical trials to assess its safety, biodistribution, pharmacokinetics, radiation dosimetry, and diagnostic performance in patients with malignant solid tumors.

02

Targets

ALPP (Alkaline phosphatase, placental type)

Beyond the preview

Go deeper on 111In-TJD-31.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 111In-TJD-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call